Medical Weight Loss for Wheeling, West Virginia Residents
Wheeling, West Virginia residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Wheeling through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Wheeling Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Wheeling, West Virginia residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Wheeling is served by telemedicine from our Costa Mesa, California clinic. The same physician-supervised semaglutide and tirzepatide programs are available by secure video, with medication shipped to your door.
Wheeling is served entirely by telehealth, so there is no local office to visit and no waiting room. We care for patients throughout the greater Wheeling area and the northern panhandle. Compounded semaglutide and tirzepatide ship directly to your door in West Virginia, and a licensed physician reviews every plan before anything is prescribed.
Our telehealth model serves Wheeling and communities across West Virginia with the same flat pricing and the same supervising physician. The first step is a $119 physician review; if you are not a candidate you are not charged, and compounded semaglutide starts at $166/month.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Wheeling
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month · just $7.70/day and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Wheeling
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Wheeling address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Wheeling
How do I get treatment from Wheeling?
As a Wheeling, West Virginia patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Wheeling?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Wheeling in cold-pack packaging, no lines and no drive.
How much does it cost for Wheeling patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Wheeling do you serve?
We serve patients from across Wheeling by telehealth, including the greater Wheeling area and the northern panhandle.
Is bilingual (Spanish) telehealth care available for Wheeling patients?
Yes. Anamaria Schmidt, our bilingual clinical coordinator, handles calls, WhatsApp, and Spanish-language consultations, with Dr. Sharma supervising every case. The full telehealth program, intake, consultation, and follow-up, is available in Spanish for Wheeling patients.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Wheeling, West Virginia by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.